palmidrol has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Petrosino, S | 1 |
| Schiano Moriello, A | 1 |
| Palma, E | 1 |
| Reyes-Ruiz, JM | 1 |
| Lopergolo, D | 1 |
| Roseti, C | 1 |
| Bertollini, C | 1 |
| Ruffolo, G | 1 |
| Cifelli, P | 1 |
| Onesti, E | 1 |
| Limatola, C | 1 |
| Miledi, R | 1 |
| Inghilleri, M | 1 |
| Clemente, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neuromuscular Magnetic Stimulation Counteracts Muscle Decline in ALS Patients[NCT03618966] | Phase 2 | 22 participants (Actual) | Interventional | 2014-11-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for palmidrol and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocan | 2020 |
1 trial available for palmidrol and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.
Topics: Action Potentials; Adult; Aged; Aged, 80 and over; Amides; Amyotrophic Lateral Sclerosis; Animals; C | 2016 |
1 other study available for palmidrol and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report.
Topics: Administration, Sublingual; Amides; Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents, Non-Ste | 2012 |